Topical composition for treatment of blepharitis
US5614545A · kind A · utility
47Cited by
1References
27Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 7, 1995 |
| Grant date | Mar 25, 1997 |
| Priority date | — |
| Expiry date | Jun 7, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0048
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition for treating blepharitis or blepharoconjunctivitis is disclosed for topical administration comprising a nitroimidazole, as metronidazole, in a suitable ophthalmic carrier to be applied directly to affected ocular tissues. The carrier may be an artificial tear solution, an ointment, a water soluble gel, a nonaqueous carrier or an eyelash shampoo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.